In the current cycle, Xeris Biopharma Holdings Inc (XERS) Stock is showing signs of growth
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
initiated: Oppenheimer Recommends Xeris Biopharma Holdings Inc (NASDAQ:XERS) Stock to “an Outperform”
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
Xeris Biopharma Holdings Inc (XERS) Stock at a key inflection point
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
Xeris Biopharma Holdings Inc (XERS) Stock: Amazing technical data that you never knew existed
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock Posted Gross Margin of 75.91 percent in Last Year: Is Justifiable?
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
What does the future hold for Xeris Biopharma Holdings Inc (XERS) Stock?
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock Posted Operating Margin of -26.85 percent in Last Year: Is Admissible?
Oppenheimer raised the price target for the Xeris Biopharma Holdings Inc (NASDAQ:XERS) stock to “an Outperform”. The rating was released on March 28, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $4. The stock was initiated by Craig Hallum, who disclosed in […]
